LARP1 and ovarian cancer: Our discovery of a correlation between circulating levels of LARP1 and tumour burden in ovarian cancer patients suggests that plasma LARP1 levels could prove a useful non-invasive means of measuring tumour LARP1 expression, which we intend to prospectively validate.